AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimytos M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Nitos Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimytos M1 Tablet PR

Metformin and glimepiride, combined in Glimytos M1 Tablet PR, effectively manage type 2 diabetes in adults. This anti-diabetic medication regulates blood glucose, requiring consistent daily use at the same time, ideally with meals. Dosage is personalized by your physician and subject to adjustment based on your blood sugar response. Continuous use is vital; premature discontinuation can lead to dangerously elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, which must include dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headache, and tremors. Always carry a rapid-acting sugar source (e.g., glucose tablets, juice) to counter this. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function as determined by your doctor.

Uses of Glimytos M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimytos M1 Tablet PR:

Follow your doctor's instructions or refer to the product label for guidance. Take Glimytos M1 Tablet PR with food.

Common Side effects of Glimytos M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimytos M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimytos M1 Tablet PR with meals.

How Glimytos M1 Tablet PR works:

Glimytos M1 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimytos M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimytos M1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimytos M1 Tablet PR are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimytos M1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glimytos M1 Tablet PR, as dose modification may be necessary. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation should be at a low dosage; however, Glimytos M1 Tablet PR is contraindicated in those with severe liver disease.

What if you forget to take Glimytos M1 Tablet PR :

Should you forget a Glimytos M1 Tablet PR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimytos M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimytos M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimytos M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimytos M1 Tablet PR and seek immediate medical attention.
Glimytos M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimytos M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimytos M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimytos M1 Tablet PR can indeed lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimytos M1 Tablet PR and alcohol is unsafe. Alcohol consumption may dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimytos M1 Tablet PR
62
MRP 72
13% off